I think it's also important to note the dosage used in this study. The study used an i.v. of 100 mg of Neridronate 4 times in 10 days. It was stated that this was a higher dose than are typically used for Paget's disease and higher than previous studies with bisphosphonates used for CRPS (studies that failed to achieve the excellent results of this article).

The equivalent dosage with Pamidronate (a bisphosphonate that is available in the U.S.) is an i.v. dose of 90 mg given 4 times over the course of 4 to 10 days.

I don't think that as good of results will be achieved with lower doses (or oral administration), but you should discuss this with your doctor.